Organization
Aptose Biosciences, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Aptose Biosciences, Inc.
... SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... SAN DIEGO and TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting ...
... SAN DIEGO and TORONTO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO), (TSX:APS), a clinical-stage company developing highly ...
... SAN DIEGO and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... CANADIAN WEEKLY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 24th largest Biotechnology company by market cap, has decreased ...
... CANADIAN WEEKLY STOCK REPORT Aptose Biosciences Inc. (TSX:APS) has risen 6.0c (or 3.1%) on high volume to close ...
... TORONTO and SEOUL, South Korea, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... CANADIAN MONTHLY STOCK REPORT Aptose Biosciences (TSX:APS), Canada's 24th largest Biotechnology company by market cap, has decreased 3.0c ...
... CANADIAN RESULTS Aptose Biosciences (TSX:APS) reported net profit for the quarter-ended 30 June 2017 of CAD3.2m ...
... CANADIAN INTRA-DAY STOCK REPORT Aptose Biosciences Inc. (TSX:APS) hit a 52-week high of CAD2.92 today for the third ...
... SAN DIEGO and TORONTO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... SAN DIEGO and TORONTO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that ...
... CANADIAN MONTHLY STOCK REPORT Aptose Biosciences (TSX:APS), Canada's 23rd largest Biotechnology company by market cap, extended its gains ...
... CANADIAN DAILY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 25th largest Biotechnology company by market cap, has plummeted ...
... CANADIAN WEEKLY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 25th largest Biotechnology company by market cap, has climbed ...
... CANADIAN DAILY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 24th largest Biotechnology company by market cap, has risen ...
... CANADIAN INTRA-DAY STOCK REPORT Aptose Biosciences Inc. (TSX:APS) extended its slide on Friday, shedding an additional 7.0c (or ...
... CANADIAN DAILY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 26th largest Biotechnology company by market cap, has dropped ...
... DAILY STOCK REPORT Corporate Wire Date: 03 July 2017 01:00 EDT Aptose Biosciences (TSX:APS) director Platzer, Erich bought 26,500 shares worth CAD29,415 on June 26. ...
... DAILY STOCK REPORT Corporate Wire Date: 03 July 2017 00:47 EDT Aptose Biosciences (TSX:APS) director Warren Whitehead bought 10,000 shares worth CAD16,400 on June 29. ...
... DAILY STOCK REPORT Corporate Wire Date: 03 July 2017 00:47 EDT Aptose Biosciences (TSX:APS) director William Rice sold 18,986 shares worth CAD22,783 on June 28. ...
... DAILY STOCK REPORT Corporate Wire Date: 03 July 2017 00:47 EDT Aptose Biosciences (TSX:APS) director William Rice bought 20,000 shares worth CAD22,800 on June 26. ...
... CANADIAN DAILY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 29th largest Biotechnology company by market cap, has dropped ...
... CANADIAN DAILY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 32nd largest Biotechnology company by market cap, extended its ...
... another bearish indicator. Price/Sales of 1.9 [0.9]. 17:00 EDT [-0.2%, 48.5%, CAD613] Aptose Biosciences closes at 8.7% below VWP Its MCap is CAD29.2 million (US$22.1 ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤